Erich is a corporate attorney in the firm’s Emerging Companies and Licensing & Technology Transactions groups.

Erich studied biology and chemistry at Davidson College, where he was a member of Phi Beta Kappa and received his B.S., magna cum laude. Before law school, Erich worked as a scientist at the Duke Human Vaccine Institute, co-authoring several publications on HIV pathogenesis and vaccine technology. He received his J.D., cum laude, from Harvard Law School.